Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species

The Journal of Infectious Diseases
Georgios ChamilosD P Kontoyiannis

Abstract

Candida species are the predominant fungal pathogens in humans and an important cause of mortality in immunocompromised patients. We developed a model of candidiasis in Toll (Tl)-deficient Drosophila melanogaster. Similar to the situation in humans, C. parapsilosis was less virulent than C. albicans when injected into Tl mutant flies. In agreement with findings in the mouse model of invasive candidiasis, cph1/cph1 and efg1/efg1 C. albicans mutants had attenuated virulence, and the efg1/efg1 cph1/cph1 double mutant was almost avirulent in Tl mutant flies. Furthermore, the conditional tet-NRG1 C. albicans strain displayed significantly attenuated virulence in flies fed food without doxycycline; virulence was restored to wild-type levels when the strain was injected into Tl mutant flies fed doxycycline-containing food. Fluconazole (FLC) mixed into food significantly protected Tl mutant flies injected with FLC-susceptible C. albicans strains, but FLC had no activity in flies injected with FLC-resistant C. krusei strains. The D. melanogaster model is a promising minihost model for large-scale studies of virulence mechanisms and antifungal drug activity in candidiasis.

Citations

Aug 15, 2009·Nature Protocols·Yiorgos Apidianakis, Laurence G Rahme
Jun 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Georgios ChamilosDimitrios P Kontoyiannis
Nov 21, 2007·Medical Mycology·Javier CapillaDavid A Stevens
Jan 15, 2008·The Journal of Infectious Diseases·Gregory A LamarisDimitrios P Kontoyiannis
Jan 18, 2008·The Journal of Infectious Diseases·Sara SpikesGregory S May
Aug 13, 2008·The Journal of Infectious Diseases·Ashraf S IbrahimBrad Spellberg
Jul 28, 2011·The Journal of Infectious Diseases·Ronen Ben-AmiDimitrios P Kontoyiannis
Dec 18, 2012·The Journal of Infectious Diseases·Russell E LewisDimitrios P Kontoyiannis
Apr 16, 2011·The Journal of Antimicrobial Chemotherapy·Josep Guarro
Nov 3, 2012·The Journal of Antimicrobial Chemotherapy·Chun-Taek OhJichan Jang
Aug 12, 2009·Eukaryotic Cell·Read Pukkila-WorleyEleftherios Mylonakis
Mar 24, 2010·Infection and Immunity·Chun-Cheih ChaoYung-Jen Chuang
Jan 12, 2012·International Journal of Microbiology·Donna M Maccallum
Apr 21, 2012·International Journal of Microbiology·Georgios HamilosDimitrios P Kontoyiannis
Oct 8, 2011·Disease Models & Mechanisms·Ethan Bier, Annabel Guichard
Mar 1, 2012·Journal of Oral Microbiology·Christina O IgboinEugene J Leys
Dec 2, 2014·Pathogens·Catherine G Harwood, Reeta P Rao
Nov 26, 2015·Expert Opinion on Drug Discovery·Maged MuhammedEleftherios Mylonakis
Jun 11, 2011·Insect Biochemistry and Molecular Biology·Norman A RatcliffePatricia Azambuja
Apr 3, 2007·Developmental and Comparative Immunology·Stephanie M Brandt, David S Schneider
Dec 21, 2006·Current Opinion in Microbiology·C Léopold Kurz, Jonathan J Ewbank
Feb 5, 2008·Cellular Microbiology·Anastasia Levitin, Malcolm Whiteway
Jul 25, 2015·FEMS Yeast Research·Hsueh-lui Ho, Ken Haynes
Oct 12, 2011·Immunological Investigations·Ronen Ben-Ami
Nov 15, 2013·Virulence·Edina K Szabo, Donna M Maccallum
Jan 8, 2015·Frontiers in Public Health·Subramani Paranthaman BalasubramaniPadmavathy Venkatasubramanian
Oct 14, 2009·Critical Reviews in Microbiology·Eveline C van AsbeckDavid A Stevens
Feb 9, 2017·Frontiers in Microbiology·Liliana ScorzoniAna M Fusco-Almeida
Feb 9, 2018·Journal of Fungi·Esther Segal, Michael Frenkel
Sep 27, 2018·Antimicrobial Agents and Chemotherapy·Aline da Graça SampaioCristiane Yumi Koga-Ito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.